Assessment of Some Metabolic and Hematological Markers in Women Exposed to in Vitro Fertilization

Launched by ASSIUT UNIVERSITY · Feb 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how in vitro fertilization (IVF) affects women's health, particularly focusing on certain metabolic and blood markers. Researchers want to understand how IVF treatments might influence things like blood sugar and inflammation levels during pregnancy, and how these factors could impact the success of the IVF process and the health of the baby. The study aims to find connections between these health markers and the outcomes of IVF, especially for women who may face challenges during pregnancy.

To participate in this trial, women must be at least 30 years old, have some type of infertility issue, and have a body mass index (BMI) between 18.5 and 38. However, women with a history of diabetes, thyroid problems, or other serious health conditions won't be eligible. If you join the study, you can expect to undergo various tests to monitor your health before and during the IVF process. This trial is not yet recruiting, but it aims to provide valuable insights that could ultimately improve IVF outcomes for women.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 30 years of age and above,
• • presenting with any infertility concern
• • BMI 18.5-38 kg/m2
• Exclusion Criteria:
• • current or past history of diabetes mellitus, thyroid dysfunction and any other chronic medical condition such as hepatic, renal, respiratory, haematological and cardiovascular disease. Other exclusion criteria included use of any therapy that may affect glucose homeostasis, thyroid and/or lipid profile